Evidence map›Paper›PMID 37864378›Full record

SynthesisBrain and behavior2023

Functional brain changes after alternative pharmacological interventions in posttraumatic stress disorder: A systematic review of clinical trials.

Shahab Lotfinia, Amin Afshar, Aram Yaseri, Miranda Olff, Yann Quidé

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Brain and behavior, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 3 countries.

Shahab LotfiniaDepartment of Clinical Psychology, School of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.ORCID 0000-0002-2533-6542
Amin AfsharFaculty of Medicine, Qazvin University of Medical Science, Qazvin, Iran.
Aram YaseriSchool of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
Miranda OlffDepartment of Psychiatry, Amsterdam University Medical Centers Location AMC, Amsterdam Public Health, Amsterdam, The Netherlands.
Yann QuidéNeuroRecovery Research Hub, School of Psychology, The University of New South Wales (UNSW) Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-8569-7139
Arq Psychotrauma Expert Group · NLQazvin University of Medical Sciences · IRShahid Beheshti University · IRShahid Beheshti University of Medical Sciences · IRUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPosttraumatic stress disorder (PTSD) is a complex and heterogeneous mental health condition that can develop after exposure to a traumatic event. Clinical trials have used alternative pharmacological agents to treat PTSD, but their associated neural correlates remain unclear. The present systematic review aims to summarize the changes in brain function associated with the use of these alternative pharmacological agents in PTSD.

methodsClinical trials using functional magnetic resonance imaging, either at rest or during the performance of tasks, were included if they compared the effects of alternative pharmacological agents between PTSD patients and either trauma-exposed controls or never-exposed healthy controls.

resultsSixteen studies were included, of which 11 used intranasal oxytocin, 2 used hydrocortisone, and 3 used delta-9-tetrahydrocannabinol (THC). Oxytocin administration was associated with the normalization of functional connectivity between the ventromedial prefrontal cortex and amygdala as well as enhanced the function of brain regions specifically involved in emotion processing (e.g., amygdala), working memory (e.g., dorsolateral prefrontal cortex), and reward (e.g., putamen). Hydrocortisone did not influence brain function at rest or during the performance of an autobiographical memory task, whereas THC was associated with the reduction of the amygdala and increased medial prefrontal cortex activation.

conclusionsThis systematic review identified preliminary evidence for normalizing brain function after the use of alternative pharmacological agents. Importantly, sex-specific differences were noted, in particular when using oxytocin, that will require further investigation.

Indexed as

Stress Disorders, Post-TraumaticBrainClinical Trials as TopicEmotionsFemaleHumansHydrocortisoneMagnetic Resonance ImagingMaleOxytocinHydrocortisoneOxytocinfunctional magnetic resonance imaginghydrocortisoneoxytocinposttraumatic stress disorder

Identifiers

PMID37864378
PMCPMC10726808
OpenAlexW4387840880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.